74 related articles for article (PubMed ID: 38199847)
1. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
[TBL] [Abstract][Full Text] [Related]
2. Severe gastrointestinal involvements in patients with adult dermatomyositis with anti-NXP2 antibody.
Fu Y; Gu L; Chen J; Dai Y; Feng Q; Chen Z; Fan J; Gao M; Wang X; Fu Q; Ye S
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38199847
[TBL] [Abstract][Full Text] [Related]
3. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature.
Xu Y; Ma X; Zhou Z; Li J; Hou J; Zhu J; Kang M; Lai J; Li X
Pediatr Rheumatol Online J; 2021 Jan; 19(1):2. PubMed ID: 33407602
[TBL] [Abstract][Full Text] [Related]
5. Association of anti-NXP2 antibody with clinical characteristics and outcomes in adult dermatomyositis: results from clinical applications based on a myositis-specific antibody.
Yan TT; Zhang X; Yang HH; Sun WJ; Liu L; Du Y; Xue J
Clin Rheumatol; 2021 Sep; 40(9):3695-3702. PubMed ID: 33712891
[TBL] [Abstract][Full Text] [Related]
6. Possible correlation between serum interleukin-8 levels and the activity of myositis in anti-NXP2 antibody-positive dermatomyositis.
Konishi R; Ichimura Y; Tanaka R; Miyahara H; Okune M; Miyamoto M; Hara M; Iwabuchi A; Takada H; Nakagishi Y; Mizuta M; Kaneko S; Shimizu M; Morio T; Nishino I; Nomura T; Okiyama N
Immunol Med; 2024 Jun; 47(2):100-105. PubMed ID: 38174692
[TBL] [Abstract][Full Text] [Related]
7. An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations.
Fredi M; Cavazzana I; Ceribelli A; Cavagna L; Barsotti S; Bartoloni E; Benucci M; De Stefano L; Doria A; Emmi G; Fabris M; Fornaro M; Furini F; Giudizi MG; Govoni M; Ghirardello A; Iaccarino L; Iannone F; Infantino M; Isailovic N; Lazzaroni MG; Manfredi M; Mathieu A; Marasco E; Migliorini P; Montecucco C; Palterer B; Parronchi P; Piga M; Pratesi F; Riccieri V; Selmi C; Tampoia M; Tripoli A; Zanframundo G; Radice A; Gerli R; Franceschini F;
Clin Rev Allergy Immunol; 2022 Oct; 63(2):240-250. PubMed ID: 35092577
[TBL] [Abstract][Full Text] [Related]
8. Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease.
Garrido-Trigo A; Corraliza AM; Veny M; Dotti I; Melón-Ardanaz E; Rill A; Crowell HL; Corbí Á; Gudiño V; Esteller M; Álvarez-Teubel I; Aguilar D; Masamunt MC; Killingbeck E; Kim Y; Leon M; Visvanathan S; Marchese D; Caratù G; Martin-Cardona A; Esteve M; Ordás I; Panés J; Ricart E; Mereu E; Heyn H; Salas A
Nat Commun; 2023 Jul; 14(1):4506. PubMed ID: 37495570
[TBL] [Abstract][Full Text] [Related]
9. Roles of focal adhesion proteins in skeleton and diseases.
Chen S; He T; Zhong Y; Chen M; Yao Q; Chen D; Shao Z; Xiao G
Acta Pharm Sin B; 2023 Mar; 13(3):998-1013. PubMed ID: 36970189
[TBL] [Abstract][Full Text] [Related]
10. Interferon-Driven Immune Dysregulation in Common Variable Immunodeficiency-Associated Villous Atrophy and Norovirus Infection.
Strohmeier V; Andrieux G; Unger S; Pascual-Reguant A; Klocperk A; Seidl M; Marques OC; Eckert M; Gräwe K; Shabani M; von Spee-Mayer C; Friedmann D; Harder I; Gutenberger S; Keller B; Proietti M; Bulashevska A; Grimbacher B; Provaznik J; Benes V; Goldacker S; Schell C; Hauser AE; Boerries M; Hasselblatt P; Warnatz K
J Clin Immunol; 2023 Feb; 43(2):371-390. PubMed ID: 36282455
[TBL] [Abstract][Full Text] [Related]
11. Clinical Heterogeneity of Patients With Antinuclear Matrix Protein 2 Antibody-Positive Myositis: A Retrospective Cohort Study in China.
Li S; Sun C; Zhang L; Han J; Yang H; Gao S; He L; Zhang P; Lu X; Shu X; Wang G
J Rheumatol; 2022 Aug; 49(8):922-928. PubMed ID: 35705242
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal Involvement in Dermatomyositis.
Matas-Garcia A; Milisenda JC; Espinosa G; Cuatrecasas M; Selva-O'Callaghan A; Grau JM; Prieto-González S
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626355
[TBL] [Abstract][Full Text] [Related]
13. Reliability of antinuclear matrix protein 2 antibody assays in idiopathic inflammatory myopathies is dependent on target protein properties.
Ichimura Y; Konishi R; Shobo M; Inoue S; Okune M; Maeda A; Tanaka R; Kubota N; Matsumoto I; Ishii A; Tamaoka A; Shimbo A; Mori M; Morio T; Kishi T; Miyamae T; Tanboon J; Inoue M; Nishino I; Fujimoto M; Nomura T; Okiyama N
J Dermatol; 2022 Apr; 49(4):441-447. PubMed ID: 34967032
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
